Oxidative Stress and Inflammation in Diabetic Micro and Macrovascular Complications

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 411

Special Issue Editors


E-Mail Website
Guest Editor
Oxidative Stress Laboratory, Basic Science Domain, Baker Heart and Diabetes Institute, Melbourne, Australia
Interests: diabetic cardiovascular complications; oxidative stress; Nrf2 activators; inflammation; NLRP3-inflammasome

E-Mail Website
Guest Editor
Oxidative Stress Laboratory, Basic Science Domain, Baker Heart and Diabetes Institute, Melbourne, Australia
Interests: endothelial dysfunction; oxidative stress; Nrf2 biology; inflammasome; diabetes-associated cardiovascular complications

Special Issue Information

Dear Colleagues,

Oxidative stress and inflammation are two key drivers of diabetic vascular disease. Novel treatment strategies that address these underlying drivers are urgently needed to lessen the burden of debilitating micro- and microvascular complications that accompany Type 1 and Type 2 diabetes.  This Special Issue will investigate novel and emerging strategies to lessen diabetic vasculopathies. Indeed, lowered oxidative stress and reduced inflammation have been linked to the most promising and newest hyperglycemia-lowering drugs, i.e., SGLT2 inhibitors, DPP4 inhibitors, and GLP-1 receptor agonists. Elucidating how these and other novel therapies improve diabetic micro- and microvascular complications will not only highlight the importance of targeting these key pathways but also strengthen their use as novel therapeutics with added vascular benefits, often independent of their glucose-lowering abilities.

Prof. Dr. Judy De Haan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Diabetic vascular complications 
  • Oxidative stress 
  • Inflammation

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop